Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Juli 2018

Planlagt Fastgjort Låst Flyttet Genmab
1.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • BulderB Offline
    BulderB Offline
    Bulder
    wrote on sidst redigeret af
    #465

    thx E L. Intracellular tumor targets in stead of surface targets!

    1 Reply Last reply
    0
    • P Offline
      P Offline
      peter12
      wrote on sidst redigeret af
      #466

      thx EL

      1 Reply Last reply
      0
      • G Offline
        G Offline
        GeorgeBest
        wrote on sidst redigeret af
        #467

        2-3 år indtil der går noget i klinikken. Ikke så langt væk....

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #468

          also on borsen for those that have access http://borsen.dk/nyheder/virksomheder/artikel/1/365636/analytiker_om_genmab-aftale_det_er_et_skridt_i_den_rigtige_retning.html?utm_source=dlvr.it&utm_medium=twitter&utm_campaign=rss_feed

          1 Reply Last reply
          0
          • P Offline
            P Offline
            Parasitism
            wrote on sidst redigeret af
            #469

            "aftalen giver indledningsvis Genmab adgang til at udnytte de tyske selskabs teknologi i tre sygdomsmål, og potentielt to mere på et senere tidspunkt. Målet er at kombinere tyskernes tilgang til kræftbehandling med Genmabs egen Duobody-teknologi i jagten på det banebrydende kræftmiddel"

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #470

              Immatics eigene bispezifische Antikörper überzeugen Genmab https://transkript.de/meldungen-des-tages/detail/immatics-eigene-bispezifische-antikoerper-ueberzeugen-genmab.html

              1 Reply Last reply
              0
              • P Offline
                P Offline
                Parasitism
                wrote on sidst redigeret af
                #471

                "Det faktum, at selskabet ikke køber et produkt eller en teknologi, men byder det tyske selskab op til samarbejde vækker tillid til projektet hos analytikerne."

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  Parasitism
                  wrote on sidst redigeret af
                  #472

                  Det er det værdiskabende, for man kunne have spurgt hvorfor Genmab har behov for at købe et aktiv, hvis selskabet selv mener, at de har en lovende teknologi - Siger Andrew Carlsen, bioanalytiker i ABG Sundal Collier. "

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    Parasitism
                    wrote on sidst redigeret af
                    #473

                    Fra Børsens artikel

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #474

                      the Amgen and Immatics for comparison on size $$ https://immatics.com/press-release/amgen-immatics-enter-strategic-collaboration-develop-novel-bispecific-cancer-immunotherapies.html

                      1 Reply Last reply
                      0
                      • G Offline
                        G Offline
                        gentogen
                        wrote on sidst redigeret af
                        #475

                        Måske også værd at bemærke, at Today’s news does not impact Genmab’s 2018 Financial Guidance.

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #476

                          England’s cost effectiveness watchdog NICE has issued draft guidance not recommending Janssen's Darzalex (daratumumab) for second line use in multiple myeloma in combination with existing treatments. http://www.pmlive.com/pharma_news/daily_brief_trump_arrives_in_london,_nice_says_no_to_darzalex,_pfizer_backs_down_on_prices_1244070

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #477

                            idiots.

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #478

                              @gentogen , that surprised me too

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #479

                                $50mio is not material anymore lol

                                1 Reply Last reply
                                0
                                • G Offline
                                  G Offline
                                  GeorgeBest
                                  wrote on sidst redigeret af
                                  #480

                                  Well the 54M $ does not impact the income statement. But it must have impact on the cash balance.

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    peter12
                                    wrote on sidst redigeret af
                                    #481

                                    Gorsky skal faktisk til møde med Trump i England i dag (før han flyver til København - sorry joking), men første del er korrekt 😉

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      peter12
                                      wrote on sidst redigeret af
                                      #482

                                      Link Preview Image
                                      Trump heads to UK, to meet with pharma execs

                                      The chief executives of Johnson & Johnson and GlaxoSmithKline are said to be attending a dinner with Trump and May.

                                      favicon

                                      Fox Business (www.foxbusiness.com)

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #483

                                        true offcourse,how wonderfull though that we dont have to worry about the cash/liquidity impact (anymore)

                                        1 Reply Last reply
                                        0
                                        • I Offline
                                          I Offline
                                          Investor13
                                          wrote on sidst redigeret af
                                          #484

                                          Dårligt nyt fra England. Burde kursen ikke falde på sådan en nyhed? Det er jo umiddelbart en stor potentiel gruppe som går tabt!

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger